Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-09-29
1989-11-14
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 514921, 536 24, 536 26, A61K 3170
Patent
active
048807834
ABSTRACT:
The invention relates to an improved cardioplegic solution for reducing ischemic damage to the heart during operations and/or transplantation. The invented solution contains adenosine, hypoxanthine and ribose in addition to the electrolytes contained in standard cardioplegic solutions.
REFERENCES:
patent: 2994640 (1961-08-01), Zellner
patent: 3868451 (1975-02-01), Stein et al.
patent: 3914414 (1975-10-01), Stein et al.
patent: 3992531 (1976-11-01), Prasad et al.
patent: 4299832 (1981-11-01), Brown et al.
patent: 4338319 (1982-07-01), Kjellin et al.
patent: 4360522 (1982-11-01), Schaeffer
patent: 4388308 (1983-06-01), Hamilton et al.
patent: 4415556 (1983-11-01), Bretschneider
patent: 4473571 (1984-09-01), Lesher et al.
patent: 4481197 (1984-11-01), Rideout et al.
patent: 4501735 (1985-02-01), Trivedi et al.
patent: 4514405 (1985-04-01), Irmscher et al.
patent: 4544556 (1985-10-01), Fedi et al.
patent: 4546095 (1985-10-01), Markov
patent: 4590180 (1986-05-01), Irmscher et al.
patent: 4593019 (1986-06-01), Bristol et al.
patent: 4605644 (1986-08-01), Foker
patent: 4614732 (1986-09-01), Hamilton et al.
patent: 4673563 (1987-06-01), Berne et al.
patent: 4693996 (1987-09-01), Steffen
Schrader et al, "Inhibitation of Slow Action Potentials of Guinea Pig A Trial Muscle by Adenosine: A Possible Effect on Ca.sup.2+ Influx,", Journal of Molecular and Cellular Cardiology (1975) 7, 427-433.
Ely et al, "Functional and Metabolic Evidence of Enhanced Myocardial Tolerance to Ischemia and Reperfusion with Adenosine," J. Thorac Cardiovase Surg. 90:549-556, (1985).
Winn et al, "Incorporation of Adenosine and Its Metabolites into Brain Nucleotides," American Physiological Society (1980), pp. H214-H219.
Wiedmeier et al., "Inosme Incorporation into Myocardial Nucleotides", Journal of Molecular and Cellular Cardiology, 4:445-452 (1972), U.S.A.
Wiedmeier et al., "Incorporation and Turnover of Adenosine-U-.sup.14 C in Perfused Guinea Pig Myocardian", Am. J. Physiology, 223(1): 31-34 (Jul. 1972), U.S.A.
Berne Robert M.
Ely Stephen W.
Lasley Robert D.
Mentzer, Jr. Robert M.
Creighton Wray James
Griffin Ronald W.
University of Virginia Alumnia Patents Foundation
LandOfFree
Use of adenosine, hypoxanthine and ribose-containing solution fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adenosine, hypoxanthine and ribose-containing solution fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine, hypoxanthine and ribose-containing solution fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1852927